Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FN4K
|
|||
| Former ID |
DIB006950
|
|||
| Drug Name |
XToll
|
|||
| Synonyms |
Heat shock protein 10 (autoimmune diseases/inflammation), CBio; Hsp10 (autoimmune diseases/inflammation), CBio; Recombinant Cpn10 (autoimmune diseases/inflammation), CBio; Recombinant chaperonin 10 (autoimmune diseases/inflammation), CBio
Click to Show/Hide
|
|||
| Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 1/2 | [1] | |
| Company |
University of Queensland
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mitochondrial 10kDa heat shock protein (HSPE1) | Target Info | Modulator | [2] |
| NetPath Pathway | TCR Signaling Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024733) | |||
| REF 2 | XToll, a recombinant chaperonin 10 as an anti-inflammatory immunomodulator. Curr Opin Investig Drugs. 2008 May;9(5):523-33. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.